Research has linked PNPLA2 to conditions such as neutrophilic lipid storage disease with myopathy and primary triglyceride deposition cardiovascular disease, with its actions spanning across pathways like glycerophospholipid biosynthesis and the modulation of insulin-like growth factor transport and uptake through insulin-like growth factor binding proteins. Here, PNPLA2 is linked to myopathy.